135 related articles for article (PubMed ID: 25387885)
1. Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer.
Marinovich ML; Houssami N; Macaskill P; von Minckwitz G; Blohmer JU; Irwig L
Int J Cancer; 2015 Jun; 136(11):2730-7. PubMed ID: 25387885
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients.
Baumgartner A; Tausch C; Hosch S; Papassotiropoulos B; Varga Z; Rageth C; Baege A
Breast; 2018 Jun; 39():19-23. PubMed ID: 29518677
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer by combining magnetic resonance imaging and core needle biopsy.
Narui K; Ishikawa T; Oba MS; Hasegawa Y; Kaise H; Kawate T; Yamada A; Yamada K; Suzuki Y; Niikura N; Kohno N; Kimoto T; Sugae S; Kosaka Y; Miyashita M; Okamura T; Shimizu D; Tanino H; Tanabe M; Morita S; Endo I; Tokuda Y
Surg Oncol; 2020 Dec; 35():447-452. PubMed ID: 33045629
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period.
Choi M; Park YH; Ahn JS; Im YH; Nam SJ; Cho SY; Cho EY
J Pathol Transl Med; 2017 Jan; 51(1):69-78. PubMed ID: 28013533
[TBL] [Abstract][Full Text] [Related]
5. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Cortazar P; Zhang L; Untch M; Mehta K; Costantino JP; Wolmark N; Bonnefoi H; Cameron D; Gianni L; Valagussa P; Swain SM; Prowell T; Loibl S; Wickerham DL; Bogaerts J; Baselga J; Perou C; Blumenthal G; Blohmer J; Mamounas EP; Bergh J; Semiglazov V; Justice R; Eidtmann H; Paik S; Piccart M; Sridhara R; Fasching PA; Slaets L; Tang S; Gerber B; Geyer CE; Pazdur R; Ditsch N; Rastogi P; Eiermann W; von Minckwitz G
Lancet; 2014 Jul; 384(9938):164-72. PubMed ID: 24529560
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
Marinovich ML; Houssami N; Macaskill P; Sardanelli F; Irwig L; Mamounas EP; von Minckwitz G; Brennan ME; Ciatto S
J Natl Cancer Inst; 2013 Mar; 105(5):321-33. PubMed ID: 23297042
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?
Maier AM; Heil J; Harcos A; Sinn HP; Rauch G; Uhlmann L; Gomez C; Stieber A; Funk A; Barr RG; Hennigs A; Riedel F; Schäfgen B; Hug S; Marmé F; Sohn C; Golatta M
Eur J Radiol; 2020 Jul; 128():109025. PubMed ID: 32371182
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of physical examination, ultrasonography, and magnetic resonance imaging in predicting response to neo-adjuvant chemotherapy for breast cancer.
Chen M; Zhan WW; Han BS; Fei XC; Jin XL; Chai WM; Wang DB; Shen KW; Wang WP
Chin Med J (Engl); 2012 Jun; 125(11):1862-6. PubMed ID: 22884043
[TBL] [Abstract][Full Text] [Related]
9. Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria.
Zhu Q; Wang L; Tannenbaum S; Ricci A; DeFusco P; Hegde P
Breast Cancer Res; 2014 Oct; 16(5):456. PubMed ID: 25349073
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MR imaging to assess response following neoadjuvant systemic treatment in various breast cancer subtypes: Comparison between different definitions of pathologic complete response.
Santamaría G; Bargalló X; Ganau S; Alonso I; Muñoz M; Mollà M; Fernández PL; Prat A
Eur J Radiol; 2019 Aug; 117():132-139. PubMed ID: 31307638
[TBL] [Abstract][Full Text] [Related]
11. Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer.
Peng J; Pu H; Jia Y; Chen C; Ke XK; Zhou Q
Medicine (Baltimore); 2021 May; 100(19):e25908. PubMed ID: 34106653
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness and relevance of intermediate endpoints for cytotoxic neoadjuvant therapy.
Fontanella C; Loibl S; von Minckwitz G
Breast; 2015 Nov; 24 Suppl 2():S84-7. PubMed ID: 26279131
[TBL] [Abstract][Full Text] [Related]
13. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment.
Bufi E; Belli P; Di Matteo M; Terribile D; Franceschini G; Nardone L; Petrone G; Bonomo L
Eur J Radiol; 2014 Sep; 83(9):1631-8. PubMed ID: 24938669
[TBL] [Abstract][Full Text] [Related]
14. Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound.
Wang X; Huo L; He Y; Fan Z; Wang T; Xie Y; Li J; Ouyang T
Chin J Cancer Res; 2016 Oct; 28(5):478-485. PubMed ID: 27877006
[TBL] [Abstract][Full Text] [Related]
15. Change in sonographic brightness can predict pathological response of triple-negative breast cancer to neoadjuvant chemotherapy.
Matsuda N; Kida K; Ohde S; Suzuki K; Yamauchi H; Nakamura S; Tsunoda H
Breast Cancer; 2018 Jan; 25(1):43-49. PubMed ID: 28536943
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Hispanic women with lymph-node positive, HER2 positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab in Mexico.
Villarreal-Garza C; Soto-Perez-de-Celis E; Sifuentes E; Ruano S; Baez-Revueltas B; Lara-Medina F; Arce-Salinas C; Alvarado-Miranda A; Chavarri-Guerra Y; Caro-Sanchez C; Castañeda-Soto N; Bargallo-Rocha E; Mohar A
Breast; 2015 Jun; 24(3):218-23. PubMed ID: 25698148
[TBL] [Abstract][Full Text] [Related]
17. Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Choi BB; Kim SH
Acta Radiol; 2015 Jul; 56(7):790-7. PubMed ID: 24951616
[TBL] [Abstract][Full Text] [Related]
18. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
[TBL] [Abstract][Full Text] [Related]
19. The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials.
Graeser M; Harbeck N; Gluz O; Würstlein R; Zu Eulenburg C; Schumacher C; Grischke EM; Forstbauer H; Dimpfl M; Braun M; Christgen M; Kreipe HH; Potenberg J; von Schumann R; Aktas B; Kolberg-Liedtke C; Kümmel S; Nitz U
Breast; 2021 Oct; 59():58-66. PubMed ID: 34166854
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Peintinger F; Kuerer HM; Anderson K; Boughey JC; Meric-Bernstam F; Singletary SE; Hunt KK; Whitman GJ; Stephens T; Buzdar AU; Green MC; Symmans WF
Ann Surg Oncol; 2006 Nov; 13(11):1443-9. PubMed ID: 17028770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
